Kura Oncology KURA Contract Liabilities
Contract Liabilities at other companies
Segments
By product
Other financials
Where this comes from
Reported directly by Kura Oncology in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kura Oncology's contract liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Kura Oncology's contract liabilities?
- Kura Oncology (KURA) reported contract liabilities of $416.75M in Q1 2026.
- How has Kura Oncology's contract liabilities changed year-over-year?
- Kura Oncology's contract liabilities increased by 53.3% year-over-year, from $271.93M to $416.75M.
- What does contract liabilities mean?
- Revenue collected or billed in advance of performance — deferred revenue under ASC 606 terminology, representing future revenue obligations.